Clinical Trials Logo

Clinical Trial Summary

This study is open to adults with a type of kidney disease called primary focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 improves the health of the kidneys in people with FSGS. Three different doses of BI 764198 are tested in this study. Participants are put into 4 groups randomly, which means by chance. Three of the groups receive different doses of BI 764198 and one group receives placebo. Participants are in the study for about 4 months. For about 3 months, they take BI 764198 or placebo as capsules once a day. Placebo capsules look like BI 764198 capsules but do not contain any medicine. Participants visit the study site about 10 times. You can participate in this study from your home. In this case a research nurse will visit you for the study visits. Kidney health is assessed based on the analysis of urine samples, which participants collect at home. At the end of the study, the results are compared between the different groups. During the study, the doctors also regularly check the general health of the participants.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05213624
Study type Interventional
Source Boehringer Ingelheim
Contact Boehringer Ingelheim
Phone 1-800-243-0127
Email [email protected]
Status Recruiting
Phase Phase 2
Start date March 10, 2022
Completion date August 21, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03907657 - Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau Phase 2
Completed NCT02468401 - Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions N/A
Completed NCT02238067 - Survey on Anemia Therapy in Patients With Chronic Kidney Disease Not on Dialysis N/A
Completed NCT01194154 - A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA) Phase 2
Completed NCT02263833 - An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice N/A
Recruiting NCT04078750 - PLATO - Medication Adherence in Transplant Recipients N/A
Active, not recruiting NCT03189212 - Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation N/A
Enrolling by invitation NCT05064267 - Hemostatic Profiles in Pediatric CKD
Not yet recruiting NCT03590067 - Oral Findings in a Group of Egyptian Pediatric Patients at Endstage Renal Disease
Recruiting NCT04014127 - Coronary Microvascular Dysfunction in Chronic Kidney Disease
Recruiting NCT04626323 - Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease Phase 2
Recruiting NCT03615235 - APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Recruiting NCT04515797 - QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir Phase 4
Active, not recruiting NCT03850756 - Early Diagnosis of Kidney Damage Associated With Tobacco Use
Recruiting NCT05249634 - Testosterone Treatment in Men With Chronic Kidney Disease Phase 2
Recruiting NCT05248412 - The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases
Not yet recruiting NCT05374291 - The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD Phase 3
Completed NCT00125593 - Study of Heart and Renal Protection Phase 4
Completed NCT03307707 - New Heart Failure Biomarkers in Early Stage Chronic Kidney Disease-Mineral and Bone Disorder N/A
Recruiting NCT05119816 - Music Therapy Intervention During Kidney Biopsy. N/A